About Protein SPMIP7
Protein SPMIP7 (SPMIP7) is a protein
from Homo sapiens identified by UniProt accession
A4D263, 438 residues long.
MolForge cross-references it against 0 known binders and
130 disease associations.
Target properties
| Protein name | Protein SPMIP7 |
| UniProt accession | A4D263 |
| Gene | SPMIP7 |
| Organism | Homo sapiens |
| Length | 438 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (130)
Diseases linked to this target (Open Targets).
- monocyte percentage of leukocytes · score 0.41
- eosinophil count · score 0.36
- basal cell carcinoma · score 0.27
- Crohn's disease · score 0.27
- inflammatory bowel disease · score 0.26
- eosinophil percentage of leukocytes · score 0.25
- keratinocyte carcinoma · score 0.22
- lymphocyte:monocyte ratio · score 0.21
- neutrophil percentage of granulocytes · score 0.20
- physical activity measurement · score 0.20
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-A4D263-F1 | alphafold | PREDICTED | 55.96 | — |
Amino-acid sequence (438 residues)
MDVEIQDTPG KISISKRSIL SGTVENIDYP HYCDLLRKMN MPFVKGLENR HNYGRFEKKC NPAFLKFHPY PPSVLPDYHL HDPYPPPYGP HYPLFPLRDD VTLGDSCSGF MSPGGDADLN PGIGRTIPTL VDFSDVKPQH RVPRPDTGFQ TTIKRQKILS EELQQNRRWN SREVPDISIR ARLGGWTSPL KVTPLQPHHE GRSLSHIFTF DEEATCTDEG EPLVQTNKKC NAKDSFYKSS TQKAYEDVPW DKMLPPKLVP EETTLEKTAD PISQCFTLKR YKGVPAITQM VGELWDRFQT RSFLAPVKPI NFVSSSSRSK YIPLYTGHVQ STNADDVDNP LGDIASLAKQ RYSKPLYTNT SRAANIPGYT GKVHFTATHP ANSNIPSTTP SPDSELHRVF QKEMAVDLFR HQAPLSRLVT TVRPYNPFNK KDKETIDY
Explore Protein SPMIP7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets